PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | -4.2% | 22,000 | 0.0% | 0.00% | – |
Q2 2022 | $24,000 | +84.6% | 22,000 | +83.3% | 0.00% | – |
Q1 2022 | $13,000 | +30.0% | 12,000 | 0.0% | 0.00% | – |
Q4 2021 | $10,000 | -79.2% | 12,000 | -66.7% | 0.00% | – |
Q3 2021 | $48,000 | +108.7% | 36,000 | +200.0% | 0.00% | – |
Q2 2021 | $23,000 | -57.4% | 12,000 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $54,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |